Neurology and Therapy (Aug 2024)

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

  • Piero Barbanti,
  • Gabriella Egeo,
  • Stefania Proietti,
  • Florindo d’Onofrio,
  • Cinzia Aurilia,
  • Cinzia Finocchi,
  • Laura Di Clemente,
  • Maurizio Zucco,
  • Alberto Doretti,
  • Stefano Messina,
  • Massimo Autunno,
  • Angelo Ranieri,
  • Antonio Carnevale,
  • Bruno Colombo,
  • Massimo Filippi,
  • Miriam Tasillo,
  • Steno Rinalduzzi,
  • Pietro Querzani,
  • Giuliano Sette,
  • Lorenzo Forino,
  • Francesco Zoroddu,
  • Micaela Robotti,
  • Alessandro Valenza,
  • Cecilia Camarda,
  • Laura Borrello,
  • Marco Aguggia,
  • Giovanna Viticchi,
  • Carlo Tomino,
  • Giulia Fiorentini,
  • Bianca Orlando,
  • Stefano Bonassi,
  • Paola Torelli,
  • for the Italian Migraine Registry study group

DOI
https://doi.org/10.1007/s40120-024-00648-z
Journal volume & issue
Vol. 13, no. 5
pp. 1505 – 1506

Abstract

Read online

No abstracts available.